会员体验
专利管家（专利管理）
工作空间（专利管理）
风险监控（情报监控）
数据分析（专利分析）
侵权分析（诉讼无效）
联系我们
交流群
官方交流：
QQ群： 891211   
微信请扫码    >>>
现在联系顾问~
下载
著录项
PDF全文
热词
    • 1. 发明申请
      WO1997003076A1 HETEROCYCLE-FUSED THIAZOLE DERIVATIVES 审中-公开
    • HETEROCYCLE-FUSED THIAZOLE DERIVATIVES
    • 杂交 - 热熔化的噻唑衍生物
    • WO1997003076A1
    • 1997-01-30
    • PCT/KR1996000082
    • 1996-06-01
    • YUNGJIN PHARMACEUTICAL CO., LTD. , YOO, Han, Yong , CHUNG, Kae, Jong , CHAI, Jun, Pyo , CHANG, Man, Sik , KIM, Sung, Gyu , CHOI, Wahn, Soo , KIM, Young, Hun , CHUN, Jae, Kwang , CHUNG, Young, Kuk , KIM, Young, Heui , PAEK, Jang, Hoon , SEO, Kwi, Hyon , KANG, Dae, Pil
    • YUNGJIN PHARMACEUTICAL CO., LTD.
    • C07D513/04
    • C07D513/04 , C07D513/14
    • A thiazole compound represented by general formula (I), wherein R is hydrogen atom, a hydroxy group, a straight or branched C1-C6 lower alkyl group, a C1-C4 lower alkoxy group, phenyl group, a phenyl group having one to three substituents selected from a group consisting of a C1-C4 lower alkyl group, a C1-C4 lower alkoxy group, fluorine, chlorine, bromine and an amino group, a C1-C5 alkylphenyl group, a phenyl group having one to three substituents selected from a group consisting of a C1-C4 lower alkyl group, a C1-C4 lower alkoxy group, fluorine, chlorine, bromine and an amino group, a substituted or unsubstituted guanidino group, or an amino group having a general formula: NR3R4 in which R3 and R4, identical to or different from each other, represent independently a hydrogen atom, a C1-C6 lower alkyl group, a C3-C6 cycloalkyl group, a substituted or unsubstituted pyridyl group, a phenyl group having one to three substituents selected from a group consisting of a C1-C4 lower alkyl group, a C1-C4 lower alkoxy group, a halogen atom, an amino group, a cyano group and a nitro group, a piperidine group or C1-C4 alkylpiperidine group; R1 and R2, identical to or different from each other, are independently a hydrogen atom, a hydroxy group, a C1-C6 lower alkyl group, phenyl group, a phenyl group having one substituent selected from a group consisting of a C1-C4 lower alkyl group, a C1-C4 lower alkoxy group, a halogen atom, a nitro and a cyano group, a C1-C5 alkylphenyl group, or a pyridine group; R5, R6, R7 and R8, identical to or different from each other, are independently a hydrogen atom, a hydroxy group, a C1-C4 lower alkyl group, a C1-C4 lower alkoxy group, phenyl group, or a phenyl group substituted with a C1-C4 alkyl group, a C1-C4 alkoxy group or a halogen atom, or a C1-C3 alkylphenyl group; Het is a 3-, 4- or 5-membered unsaturated monocyclic group, or 6- to 12-membered unsaturated fused cyclic group, said monocyclic and fused cyclic group being comprised of one or more hetero atoms selected from oxygen, oxidative nitrogen and oxidative sulfur atom are disclosed. These compounds show excellent anti-ulcer activity.
    • 由通式（I）表示的噻唑化合物，其中R是氢原子，羟基，直链或支链C 1 -C 6低级烷基，C 1 -C 4低级烷氧基，苯基，具有1至3个 选自C1-C4低级烷基，C1-C4低级烷氧基，氟，氯，溴和氨基的取代基，C1-C5烷基苯基，具有1〜3个选自 由C1-C4低级烷基，C1-C4低级烷氧基，氟，氯，溴和氨基组成的基团，取代或未取代的胍基，或具有通式NR 3 R 4的氨基，其中R 3 和R 4彼此相同或不同，分别独立地表示氢原子，C1-C6低级烷基，C3-C6环烷基，取代或未取代的吡啶基，具有1〜3个选自 由C1-C4低级烷基组成的组 C1-C4低级烷氧基，卤素原子，氨基，氰基和硝基，哌啶基或C1-C4烷基哌啶基; R1和R2彼此相同或不同，独立地为氢原子，羟基，C1-C6低级烷基，苯基，具有一个取代基的苯基，所述取代基选自C1-C4低级 烷基，C1-C4低级烷氧基，卤素原子，硝基和氰基，C1-C5烷基苯基或吡啶基; R5，R6，R7和R8彼此相同或不同，独立地为氢原子，羟基，C1-C4低级烷基，C1-C4低级烷氧基，苯基或苯基取代 C1-C4烷基，C1-C4烷氧基或卤原子，或C1-C3烷基苯基; Het是3-，4-或5-元不饱和单环基团，或6至12元不饱和稠合环基团，所述单环和稠环基团由一个或多个选自氧，氧化氮和氧化氮的杂原子组成 硫原子。 这些化合物显示出优异的抗溃疡活性。
    • 基本信息 添加关注 加入工作空间 PDF全文 PDF下载 全文下载 相似专利 双屏查看 权利要求书 说明书全文 Global Dossier Espacenet 法律信息 同族专利 专利引用
    • 2. 发明申请
      WO1997003073A1 THIAZOLYL TRIAZOLOTHIAZOLE DERIVATIVES 审中-公开
    • THIAZOLYL TRIAZOLOTHIAZOLE DERIVATIVES
    • 三唑并噻唑衍生物
    • WO1997003073A1
    • 1997-01-30
    • PCT/KR1996000079
    • 1996-06-01
    • YUNGJIN PHARMACEUTICAL CO., LTD. , YOO, Han, Yong , CHUNG, Kae, Jong , CHAI, Jun, Pyo , CHANG, Man, Sik , KIM, Sung, Gyu , CHOI, Wahn, Soo , KANG, Dae, Pil , KIM, Young, Hun , KIM, Young, Heui , WOO, Tae, Wook , PAEK, Jang, Hoon , SEO, Kwi, Hyon
    • YUNGJIN PHARMACEUTICAL CO., LTD.
    • C07D417/04
    • C07D513/04
    • Novel thiazolyl triazolothiazole derivatives represented by general formula (I); wherein, R is hydrogen atom, a hydroxy group, a straight or branched C1 - C6 lower alkyl group, a C1 - C6 lower alkoxy group, a substituted or unsubstituted phenyl or pyridyl group, a substituted or unsubstituted guanidino group, or an amino group having a general formula : NR4R5 in which R4 and R5, identical to or different from each other, represent independently hydrogen atom, a C1 - C6 lower alkyl group, a C3 - C6 cycloalkyl group, a substituted or unsubstituted phenyl or pyridyl group, a C1 - C4 lower alkyl group, a C1 - C6 lower alkoxy group, or a C1 - C4 lower alkylphenyl group; R2 and R3, identical to or different from each other, are independently hydrogen atom, a C1 - C4 lower alkyl group, or a phenyl group which may be substituted; and X and Y, different from each other, are independently nitrogen atom or a group of a formula: CR6 in which R6 is hydrogen atom, a C1 - C6 lower alkyl group, or a phenyl group which may be substituted, and pharmaceutically acceptable salts thereof are disclosed. These compounds show excellent anti-ulcer activity.
    • 由通式（I）表示的新型噻唑基三唑并噻唑衍生物; 其中，R为氢原子，羟基，直链或支链C1-C6低级烷基，C1-C6低级烷氧基，取代或未取代的苯基或吡啶基，取代或未取代的胍基或氨基 具有通式：其中R4和R5彼此相同或不同的NR4R5独立地表示氢原子，C1-C6低级烷基，C3-C6环烷基，取代或未取代的苯基或吡啶基， C1-C4低级烷基，C1-C6低级烷氧基或C1-C4低级烷基苯基; R2和R3彼此相同或不同，独立地为氢原子，C1-C4低级烷基或可被取代的苯基; 并且X和Y彼此不同，独立地为氮原子或式为CR 6的基团，其中R 6为氢原子，C 1 -C 6低级烷基或可被取代的苯基，以及药学上可接受的盐 公开。 这些化合物显示出优异的抗溃疡活性。
    • 基本信息 添加关注 加入工作空间 PDF全文 PDF下载 全文下载 相似专利 双屏查看 权利要求书 说明书全文 Global Dossier Espacenet 法律信息 同族专利 专利引用
    • 4. 发明申请
      WO1997003074A1 4-AMINO-3-ACYLNAPHTHYRIDINE DERIVATIVES 审中-公开
    • 4-AMINO-3-ACYLNAPHTHYRIDINE DERIVATIVES
    • 4-氨基-3-乙酰基吡啶衍生物
    • WO1997003074A1
    • 1997-01-30
    • PCT/KR1996000080
    • 1996-06-01
    • YUNGJIN PHARMACEUTICAL CO., LTD. , YOO, Han, Yong , CHUNG, Kae, Jong , CHANG, Man, Sik , KIM, Sung, Gyu , CHOI, Wahn, Soo , KANG, Dae, Pil , KIM, Young, Hun , PAEK, Jang, Hoon , SOHN, Sang, Kwon , KANG, Bog, Goo , KIM, Young, Heui , SEO, Kwi, Hyon
    • YUNGJIN PHARMACEUTICAL CO., LTD.
    • C07D471/04
    • C07D471/04
    • A novel 4-amino-3-acylnaphthyridine derivatives represented by general formula (I), wherein R1 is hydrogen atom, a C1-C6 lower alkyl group, a C1-C6 lower alkoxy group, a C1-C6 lower alkoxyalkyl group, a C3-C6 cycloalkyl group, a C3-C6 cycloalkyl C1-C6 alkyl group, a substituted or unsubstituted phenyl, or a phenyl C1-C6 alkyl group of which phenyl group may be substituted; R2 is hydrogen atom, a C1-C6 lower alkyl group, a C1-C6 alkoxy group, a C1-C6 alkylthio group, or a group of a formula: NR6R7 wherein R6 and R7, identical to or different from each other, are independently hydrogen atom or a C1-C6 lower alkyl group, or R6 and R7 may form together 5-membered or 6-membered cycloalkyl group; R3 is hydrogen atom, a C1-C6 lower alkyl group, a C1-C6 alkoxy group, a C1-C6 alkylthio group, an amino group substituted with one or two C1-C6 alkyl groups, a halogen atom, a cyano group, a C1-C6 alkanoyl group, or trifluoromethyl group; R4 is hydrogen atom or a substituted or unsubstituted C1-C6 alkyl group; R5 is hydrogen atom, a C1-C6 lower alkyl group, a C1-C6 alkoxy group, an amino group substituted with one or two C1-C6 alkyl groups, a C1-C6 alkylthio group, a halogen atom, a cyano group, a hydroxycarbamoyl group, a carboxy group, a C1-C6 alkanoyl group, or trifluoromethyl group, or an alkyl group which forms together with R4 a 5-membered or 6-membered cycloalkyl group; m is an integer from 0 to 4, inclusive; and n is an integer from 1 to 3, inclusive; with proviso that all alkyl and alkoxy groups may be linear or branched, and said halogen atom means fluorine, chlorine or bromine atom, or its pharmaceutically acceptable salts are disclosed. These compounds show excellent anti-ulcer activity.
    • 一种由通式（I）表示的新型4-氨基-3-酰基萘啶衍生物，其中R1是氢原子，C1-C6低级烷基，C1-C6低级烷氧基，C1-C6低级烷氧基烷基，C3 C 6环烷基，C 3 -C 6环烷基C 1 -C 6烷基，取代或未取代的苯基或苯基可以被取代的苯基C 1 -C 6烷基; R 2是氢原子，C 1 -C 6低级烷基，C 1 -C 6烷氧基，C 1 -C 6烷硫基或式-NR 6 R 7基团，其中R 6和R 7彼此相同或不同，独立地是 氢原子或C1-C6低级烷基，或R6和R7可以一起形成5元或6元环烷基; R3是氢原子，C1-C6低级烷基，C1-C6烷氧基，C1-C6烷硫基，被一个或两个C1-C6烷基取代的氨基，卤素原子，氰基， C1-C6烷酰基或三氟甲基; R4是氢原子或取代或未取代的C1-C6烷基; R5是氢原子，C1-C6低级烷基，C1-C6烷氧基，被一个或两个C1-C6烷基取代的氨基，C1-C6烷硫基，卤素原子，氰基， 羟基氨基甲酰基，羧基，C1-C6烷酰基或三氟甲基，或与R4一起形成5元或6元环烷基的烷基; m为0〜4的整数，包括0和4; n为1〜3的整数， 条件是所有烷基和烷氧基可以是直链或支链的，并且所述卤素原子是指氟，氯或溴原子，或其药学上可接受的盐。 这些化合物显示出优异的抗溃疡活性。
    • 基本信息 添加关注 加入工作空间 PDF全文 PDF下载 全文下载 相似专利 双屏查看 权利要求书 说明书全文 Global Dossier Espacenet 法律信息 同族专利 专利引用
    • 7. 发明申请
      WO1997003077A1 BENZ- OR PYRIDO-IMIDAZOLE DERIVATIVES 审中-公开
    • BENZ- OR PYRIDO-IMIDAZOLE DERIVATIVES
    • 苄基或吡唑并咪唑衍生物
    • WO1997003077A1
    • 1997-01-30
    • PCT/KR1996000081
    • 1996-06-01
    • YUNGJIN PHARMACEUTICAL CO., LTD. , YOO, Han, Yong , CHUNG, Kae, Jong , CHANG, Man, Sik , KIM, Sung, Gyu , CHOI, Wahn, Soo , KANG, Dae, Pil , LEE, Jeong, Min , PAEK, Jang, Hoon , KIM, Kyu, Bong , PARK, Sung, Hoon , KIM, Young, Hun , KIM, Young, Heui , SEO, Kwi, Hyon
    • YUNGJIN PHARMACEUTICAL CO., LTD.
    • C07D513/14
    • C07D513/14
    • A benz- or pyrido-imidazole compounds represented by general formula (I), wherein R is hydrogen atom, a hydroxy group, a C1-C6 lower alkyl group, a C1-C6 lower alkoxy group, a substituted or unsubstituted phenyl or pyridyl group, a substituted or unsubstituted guanidino group, or an amino group having a general formula: NR3R4 in which R3 and R4, identical to or different from each other, represent hydrogen atom, a C1-C6 lower alkyl group, a C3-C6 cyclic alkyl group, a substituted or unsubstituted phenyl or pyridyl group, a C1-C6 lower alkoxy group, a C2-C6 alkyl group, or phenyl alkyl group; R1 and R2, identical to or different from each other, are hydrogen atom, a C1-C6 lower alkyl group, a C1-C6 lower alkoxy group, an amino group which may be substituted with a C1-C2 alkyl group, a C1-C6 alkoxy carbonyl group, a halogen atom, a cyano group, a C1-C6 alkylthio group, or a C1-C6 acyl group; R6 is hydrogen atom, a C1-C6 lower alkyl group, a C1-C3 lower alkoxy group, a halogen atom, or a hetero atom; n is an integer from 0 to 4, inclusive; and X is a nitrogen atom or CR5 wherein R5 is hydrogen atom, a C1-C6 lower alkyl group, a C1-C6 lower alkoxy group, or a halogen atom, or its pharmaceutically acceptable salts are disclosed. These compounds show excellent anti-ulcer activity.
    • 由通式（I）表示的苯并或吡啶并咪唑化合物，其中R为氢原子，羟基，C1-C6低级烷基，C1-C6低级烷氧基，取代或未取代的苯基或吡啶基 取代或未取代的胍基或具有以下通式的氨基：NR 3 R 4，其中R 3和R 4彼此相同或不同，表示氢原子，C1-C6低级烷基，C3-C6环烷基 基团，取代或未取代的苯基或吡啶基，C1-C6低级烷氧基，C2-C6烷基或苯基烷基; R1和R2相同或不同，为氢原子，C1-C6低级烷基，C1-C6低级烷氧基，可被C1-C2烷基取代的氨基，C1- C6烷氧基羰基，卤素原子，氰基，C1-C6烷硫基或C1-C6酰基; R6是氢原子，C1-C6低级烷基，C1-C3低级烷氧基，卤素原子或杂原子; n是0至4的整数，包括0和4; X是氮原子或其中R5是氢原子，C1-C6低级烷基，C1-C6低级烷氧基或卤素原子的CR5或其药学上可接受的盐。 这些化合物显示出优异的抗溃疡活性。
    • 基本信息 添加关注 加入工作空间 PDF全文 PDF下载 全文下载 相似专利 双屏查看 权利要求书 说明书全文 Global Dossier Espacenet 法律信息 同族专利 专利引用
每页展示10个专利
每页展示10个专利
每页展示20个专利
每页展示50个专利
每页展示100个专利

IPRDB

最新中国发明专利 最新美国发明专利 技术领域 专利库 专利分类库 国际专利分类库

热门服务

会员版试用 API 数据接口 找代理 知嘟嘟专利交易 排行榜 大学排行榜 专利百科

关于我们

平台介绍 战略合作 网站地图

友情链接

知嘟嘟专利交易 国家知识产权局 中国商标网

联系方式


©2019-2023 上海吉码数字技术有限公司 版权所有，并保留所有权利 沪ICP备20016256号-6 沪公网安备31011702005475号